ENSG

Ensign Group, Inc

$166.83 -1.39 (-0.83%) At close · Jul 6

Market Cap

$9.75B

58,445,400

Equibles Rating blended score · not investment advice

Overall

Neutral

Technical · trend & momentum Neutral

◦ 50 / 200-day cross no cross

− Price vs 200-day avg −9% below

◦ Price vs 50-day avg −2% below

◦ RSI (14) 54 · neutral

+ MACD trend positive

◦ 52-week position 39% · mid-range

Sentiment · smart money Bearish

◦ Trend (MA cross) 50d $169 › 200d $183 — 200d above 50d

− Institutional flow 7 of 571 funds reported for Jun 30 · net -24 sh shares

− Insider flow Net -$340.6K over 90 days · 100% sells

− Short interest 4.59% of float · ▲ +19.1% MoM · 2.6 days cover

◦ Volume signal Volume near normal

+ Institution breadth 571 holders — near 3-yr high, broad support

Fundamentals Excellent

+ Revenue growth +19% Y/Y

+ EPS growth +14% Y/Y

+ Free cash flow $492.7M

− Valuation P/E 27.2 · rich

+ Buyback $20.0M remaining

+ Balance sheet net cash $359.5M

Blended from price, positioning & fundamentals · daily-close · not investment advice.

Up next

Next earnings call

Jul 29, 2026 Est · unconfirmed · in 3 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed Apr 30, 2026

Guidance & track record what management promised — and delivered

Latest guidance · from the 8-K filed Apr 30, 2026

Earnings per diluted share · annual 2026 Initiated $7.48 – $7.62

prior FY $5.84 midpoint +29.3% Y/Y

Annual revenue · annual 2026 Initiated $5.81B – $5.86B

prior FY $5.06B midpoint +15.4% Y/Y

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral

1 · 4 · 1

50 / 200-day cross

no cross Neutral

Price vs 200-day avg

−9% below Bearish

Price vs 50-day avg

−2% below Neutral

RSI (14)

54 · neutral Neutral

MACD trend

positive Bullish

52-week position

39% · mid-range Neutral

Market signals — smart money & positioning

Bearish · 3 of 6

Trend (MA cross) No cross

50d $169 › 200d $183 — 200d above 50d

Institutional flow Distributing

7 of 571 funds reported for Jun 30 · net -24 sh shares

Insider flow Distributing

Net -$340.6K over 90 days · 100% sells

Short interest Rising

4.59% of float · ▲ +19.1% MoM · 2.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

571 holders — near 3-yr high, broad support

Price context

position in its 52-week range

52-wk low $135 Now $167 · 39% 52-wk high $218

vs 200-day avg -9% vs 50-day avg -2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings

Metric	Latest	Period	YoY
Funds from Operations (FFO) non-GAAP	21.6M	Q1 2026	—
Same Facilities occupancy	84.3%	Q1 2026	—

Transitioning Facilities occupancy	85.1%	Q1 2026	—

new independent living units added	55	Q1 2026 call	—
new operations added in the quarter	22	Q1 2026 call	—
new senior living units added	100	Q1 2026 call	—
new skilled nursing beds added	2,662	Q1 2026 call	—
operations acquired during 2025 and since	71	2025 and since call	—
operations acquired since 2024	99	since 2024 call	—
operations at 4- or 5-star quality measures	85%	Q1 2026 call	—
recently acquired operations as percentage of portfolio	17.4%	Q1 2026 call	—
same-store managed care census sequential growth	6.2%	Q4 2025 to Q1 2026 call	—
same-store Medicare census sequential growth	8.3%	Q4 2025 to Q1 2026 call	—
same-store Medicare revenue growth	9.8%	Q1 2026 call	—
same-store occupancy	84.3%	Q1 2026 call	—
same-store outperformance vs peers in 5-star quality measures at state level	20%	Q1 2026 call	—
same-store outperformance vs peers in 5-star quality measures nationally	24%	Q1 2026 call	—
same-store outperformance vs peers in annual survey at county level	31%	Q1 2026 call	—
same-store outperformance vs peers in annual survey at state level	22%	Q1 2026 call	—
same-store skilled revenue growth	9.6%	Q1 2026 call	—
transitioning Medicare revenue growth	9.2%	Q1 2026 call	—
transitioning occupancy	85.1%	Q1 2026 call	—
Same Facilities skilled days	6.8%	the year ended December 31, 2025	—
Transitioning Facilities skilled days	10.7%	the year ended December 31, 2025	—

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Medical Care Facilities — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
ENSG Ensign Group, Inc this stock	$9.75B	-4.2%	+18.7%	27.2	4.6%
HCA HCA Healthcare, Inc.	$92.52B	-10.5%	+7.1%	14.4	2.4%
FSNUY Fresenius SE & Co. KGaA	$28.16B	-12.8%	—	—	0.0%
THC Tenet Healthcare Corp	$17.76B	+3.8%	-2.3%	10.7	4.7%
DVA Davita Inc.	$15.13B	+107.5%	+6.5%	22.0	7.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

571

% held: 86.3%
Reported: 7 of 571
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

494

View

Short & Settlement

Short Interest Rising

Shares short

2.7M

Days to cover: 2.6d
Change: +430.1K sh

View

Short Volume

Short vol %

51%

As of: Jul 6, 2026

Short Total

View

Fails to Deliver

FTD shares

452

Value: $70.2K
As of: Jun 10, 2026

View

Off-Exchange

Off-exchange %

48.5%

Week of: May 4, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$340.6K

Buyers / Sellers: 0 / 3

Buyers Sellers

View

Financials

Revenue (FY)

$5.1B

Net income (FY): $344.0M
EPS diluted: $5.84

View

Buybacks

Authorized

$100.0M

Remaining: $20.0M

Spent Remaining

View

Filings

SEC Filings

Latest

8-K

Filed: Jun 15, 2026
This year: 8

View

Proposed Sales

Value

$115.0K

Shares: 700
Filed: Jun 2, 2026

View

Earnings & Events

Earnings Calls

Last call

Apr 30, 2026

View

Investor Relations

Performance

	5D	20D	120D	MTD	YTD
ENSG	+2.3%	+1.6%	-4.0%	+4.1%	-4.2%
SPY	+3.1%	-0.8%	+8.2%	+0.6%	+10.2%
vs SPY	-0.7%	+2.3%	-12.3%	+3.5%	-14.4%

Capital returns

Latest dividend

$0.065 / share · ex Jun 30, 2026

Raised 3.2%

Paid (TTM)

$0.258 / share · 4 payouts

Dividend yield (TTM, derived)

0.15%

Buyback program · as of Mar 31, 2026

Authorized

$100.00M

Spent (derived)

$80.00M

Remaining

$20.00M

Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1125376 CUSIP 29358P101 13F (30d) 12 filings 10 filers Visit website Investor relations

ENSG

Price & Indicators

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns